Keep reading to learn how nasal sumatriptan works, who could benefit, and how it compares with other types of sumatriptan.

It markets two of the ten top-selling consumer healthcare brands – multivitamin tablets Centrum and headache pill Advil ... These include GlaxoSmithKline, though it is already looking to ...

Similarly, whilst GlaxoSmithKline’s origins can be traced ... and even drugs as ubiquitous as paracetamol and ibuprofen were developed in 1956 and 1969 respectively. As the 1970s drew to an ...

Wellnex has forged some smart partnerships, including the collaboration with Chemist Warehouse on Wagner Liquigesic (paracetamol, paracetamol and ibuprofen ... a spin-off from GlaxoSmithKline ...

“Pain is inevitable…Advil keeps me going,” reads the text on screen of a recent Instagram Reel for hybrid athlete MaKayla Bassi (more than 90,000 followers) while she’s running on a track.

GlaxoSmithKline share price jumped more than 17% on Tuesday and extended its surge for the third consecutive session. GlaxoSmithKline shares spiked as much as 17.69% to ₹2,744.95 apiece on the ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The company’s shares closed last Friday at p1,466. ...

Bernstein analyst Florent Cespedes maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £22.90. The company’s shares opened today at p1,443. ...

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention ...

Ibuprofen is a type of nonsteroidal anti-inflammatory drug, or NSAID, that is used to relieve pain, fever, and inflammation. It is often recommended for maladies such as back pain, toothache ...

Commenting on the results, Bhushan Akshikar, MD of GlaxoSmithKline Pharmaceuticals, highlighted the company’s strategic initiatives in strengthening its market presence and enhancing access to ...

It has been about a month since the last earnings report for GSK (GSK). Shares have added about 8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...